Variant report
Variant | esv1002306 |
---|---|
Chromosome Location | chr6:33797224-33797809 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:33796210..33797861-chr6:33802037..33804475,2 | MCF-7 | breast: | |
2 | chr6:33795530..33798300-chr6:33803409..33806426,4 | MCF-7 | breast: | |
3 | chr6:33793637..33795279-chr6:33797318..33799112,2 | MCF-7 | breast: | |
4 | chr6:33794679..33797387-chr6:33799948..33801747,2 | MCF-7 | breast: | |
5 | chr6:33755377..33757050-chr6:33795236..33797558,2 | MCF-7 | breast: | |
6 | chr6:33795996..33798344-chr6:33806425..33808689,2 | K562 | blood: | |
7 | chr6:33794613..33797241-chr6:33797718..33800343,2 | K562 | blood: | |
8 | chr6:33794613..33797241-chr6:33797718..33800343,2 | K562 | blood: | |
9 | chr6:33792540..33794242-chr6:33797299..33799523,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000161904 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs73747336 | chr6:33797241-33797242 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs541911459 | chr6:33797246-33797247 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs185947244 | chr6:33797271-33797272 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs371323905 | chr6:33797285-33797286 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs188316362 | chr6:33797286-33797287 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs9469604 | chr6:33797296-33797297 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs10947451 | chr6:33797318-33797319 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs373474885 | chr6:33797342-33797343 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs576185381 | chr6:33797352-33797353 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs180877052 | chr6:33797356-33797357 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs537179549 | chr6:33797391-33797392 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs368629827 | chr6:33797394-33797395 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs558777602 | chr6:33797410-33797411 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs58162883 | chr6:33797442-33797443 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs58356614 | chr6:33797448-33797449 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs369703835 | chr6:33797452-33797453 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs374352965 | chr6:33797455-33797456 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs58256826 | chr6:33797467-33797468 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs9469605 | chr6:33797493-33797494 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs547561986 | chr6:33797498-33797499 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs571027095 | chr6:33797503-33797504 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs61522556 | chr6:33797504-33797505 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs56799964 | chr6:33797508-33797509 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs58338371 | chr6:33797511-33797512 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs58812103 | chr6:33797518-33797519 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs577159449 | chr6:33797524-33797525 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs9469606 | chr6:33797549-33797550 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs541270974 | chr6:33797553-33797554 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs113882006 | chr6:33797573-33797574 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs559394734 | chr6:33797578-33797579 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs527347568 | chr6:33797606-33797607 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs9469607 | chr6:33797607-33797608 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs9394170 | chr6:33797614-33797615 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs112733238 | chr6:33797628-33797629 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs9469608 | chr6:33797683-33797684 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs9469609 | chr6:33797738-33797739 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs137909775 | chr6:33797757-33797758 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560974141 | chr6:33797778-33797779 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs185293233 | chr6:33797784-33797785 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186527781 | chr6:33797793-33797794 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542726786 | chr6:33797806-33797807 | Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Systemic lupus erythematosus | 19279649 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Acute myocardial infarction | 18032375 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Systemic lupus erythematosus | 19591781 | CNVD |
Attention deficit hyperactivity disorder | 19287146 | CNVD |
Autism | 19287146 | CNVD |
Erythema nodosum in leprosy | 19287146 | CNVD |
Henoch-schoenlein purpura | 19287146 | CNVD |
Liver cirrhosis | 19287146 | CNVD |
Systemic lupus erythematosus | 19287146 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Systemic lupus erythematosus | 19287147 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:33793000-33798800 | Weak transcription | Spleen | Spleen |
2 | chr6:33794600-33799400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr6:33795000-33799600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
4 | chr6:33795800-33798000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr6:33795800-33798600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr6:33796000-33798000 | Enhancers | Right Ventricle | heart |
7 | chr6:33796000-33798200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr6:33796400-33797800 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
9 | chr6:33796600-33798000 | Weak transcription | Rectal Smooth Muscle | rectum |
10 | chr6:33796800-33798400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr6:33796800-33798800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr6:33797000-33797800 | Enhancers | Stomach Smooth Muscle | stomach |
13 | chr6:33797000-33798200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr6:33797000-33798800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
15 | chr6:33797200-33797800 | Weak transcription | Colon Smooth Muscle | Colon |
16 | chr6:33797200-33797800 | Weak transcription | Ovary | ovary |
17 | chr6:33797200-33798200 | Weak transcription | H1 Cell Line | embryonic stem cell |
18 | chr6:33797200-33798800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
19 | chr6:33797200-33801800 | Weak transcription | A549 | lung |
20 | chr6:33797200-33805600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
21 | chr6:33797800-33798000 | Bivalent Enhancer | iPS-20b Cell Line | embryonic stem cell |
22 | chr6:33797800-33798000 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
23 | chr6:33797800-33798000 | Enhancers | Colon Smooth Muscle | Colon |
24 | chr6:33797800-33798000 | Enhancers | Ovary | ovary |
25 | chr6:33797800-33798000 | Flanking Active TSS | Stomach Smooth Muscle | stomach |